Vanguard Selected Value Inv (VASVX)
Nasdaq • Currently down 0.04 (-0.13%) in today's trading session
1 member of Congress has disclosed 3 trades in Vanguard Selected Value Inv (VASVX) via STOCK Act filings. The most recent disclosure was a sale by Lloyd Doggett on 27 December 2022. Aggregate disclosed activity totals roughly $75K in purchases and $65K in sales (midpoint estimates from bracketed disclosure amounts).
Vanguard Selected Value Inv is currently trading at $31.64, positioned at 97% of its 52-week range ($25.72 – $31.85).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Vanguard Selected Value Inv Price History and Technical Analysis
Congressional Trading Activity for VASVX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about VASVX
- Which members of Congress have traded VASVX?
- 1 member of Congress has disclosed 3 trade in Vanguard Selected Value Inv (VASVX) under the STOCK Act: Lloyd Doggett.
- When was VASVX most recently disclosed by Congress?
- The most recent VASVX disclosure was a sale by Lloyd Doggett on 27 December 2022.
- What is the total disclosed congressional trading volume for VASVX?
- Members of Congress have disclosed approximately $75K in VASVX purchases and $65K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
- How can I track new congressional trades in VASVX?
- This VASVX page updates as soon as new STOCK Act disclosures are filed for Vanguard Selected Value Inv. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track VASVX in Congress
See when politicians buy or sell this stock